We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Optical Scintillation Detector Monitors Radiation Treatments

By HospiMedica International staff writers
Posted on 15 Nov 2017
A new system provides diagnostic pinpoint accuracy measurement of the radiation treatment plan by verifying the dose delivered is consistent with the prescribed dose.

The RadiaDyne (Houston, TX, USA) OARtrac system is a real-time in vivo dosimetry device system that uses disposable scintillating detectors during stereotactic body radiotherapy (SBRT) and intensity-modulated radiation therapy (IMRT) for prostate cancer treatment or brachytherapy. More...
The system is based on plastic scintillation detector (PSD) probes connected to a duplex fiber-optical cable that transmits the PSD signals to a charge coupled device (CCD) camera that measures the scintillator output signal.

The optical measurement is converted to an electrical signal and displayed on a digital readout located in the control room of the linear accelerator treatment machine. Based on the continuous review of the accumulative dose data provided by the system, radiation oncologists can adjust subsequent treatment if and when required, thus allowing for a true adaptive radiation therapy protocol. The PSD sensor cable can be used up to five times on the same patient.

“Radiation oncologists can now monitor multiple radiation delivery modalities within the same treatment center, as well as reduce overall treatment costs related to routine patient dose monitoring,” said John Isham, founder of RadiaDyne.

Organs at risk (OAR) are defined as normal tissues whose radiation sensitivity may significantly influence treatment planning and/or the prescribed radiation dose.

Related Links:
RadiaDyne


Gold Member
Neonatal Heel Incision Device
Tenderfoot
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Fetal Monitor
BT-380
Medical Examination & Procedure Light
Vega 80
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Graphical Abstract (Aoibhin M. Sheedy et al., A replenishable peritoneal implant for localized delivery and peritoneal fluid sampling in ovarian cancer, Device (2026). DOI: 10.1016/j.device.2026.101050)

New Implant Provides Sustained Localized Therapy for Ovarian Cancer

Ovarian cancer is often diagnosed at advanced stages because symptoms such as bloating, pain, and pelvic pressure are nonspecific. Standard care relies on surgery and systemic therapy, yet tools for targeted... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.